Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T07:17:51.488Z Has data issue: false hasContentIssue false

Evidence for reduced frontal cortical thickness in long-term heavy cannabis users

Published online by Cambridge University Press:  31 July 2026

A. Aquino-Servin*
Affiliation:
FIDMAG Germanes Hospitalàries Research FoundationPrograma de Doctorat en Biomedicina, Universitat de Barcelona
P. Fuentes-Claramonte
Affiliation:
FIDMAG Germanes Hospitalàries Research FoundationCIBERSAM ISCIII
N. Hostalet
Affiliation:
FIDMAG Germanes Hospitalàries Research FoundationPrograma de Doctorat en Biomedicina, Universitat de Barcelona
I. París-Gómez
Affiliation:
FIDMAG Germanes Hospitalàries Research FoundationPrograma de Doctorat en Biomedicina, Universitat de Barcelona
P. del Olmo-Encabo
Affiliation:
FIDMAG Germanes Hospitalàries Research Foundation
M. Madre
Affiliation:
Mental Health, IR SANT PAU, Hospital de la Santa Creu i Sant Pau
X. Roca
Affiliation:
Mental Health, IR SANT PAU, Hospital de la Santa Creu i Sant Pau
F. Panicali
Affiliation:
Fundació Hospitalàries Sant Boi
A. Romaguera
Affiliation:
Fundació Hospitalàries Barcelona Nord, Barcelona
M. Á. García-León
Affiliation:
Department of Personality, Assessment, and Psychological Treatments, Universidad de Sevilla, Sevilla, Spain
P. J. McKenna
Affiliation:
FIDMAG Germanes Hospitalàries Research Foundation
E. Pomarol-Clotet
Affiliation:
FIDMAG Germanes Hospitalàries Research FoundationCIBERSAM ISCIII
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Although cannabis use is often regarded as relatively harmless, structural imaging studies have found variable evidence for volume reductions in the hippocampus and orbitofrontal cortex (OFC) among other regions (Lorenzetti et al. Eur Arch Psychiatry Clin Neurosci; 269 59-71; Soleimani et al. Sci Rep 2023; 13 5847; Mashhoon et al. Drug Alcohol Depend. 2015; 155 275-83; Wittemann et al. Eur. Addict. Res. 2021; 27 115-22). These studies have mostly focused on adolescents and young adult users, and studies in long-term, heavy cannabis users, who would be arguably most likely to show structural alterations, are few.

Objectives

The aim of this study is to examine different morphological metrics at the whole-brain level, including volume, surface area and cortical thickness in long-term, heavy cannabis users.

Methods

We carried out 3T structural imaging in 41 cannabis users with ≥10 years of use and ≥5 years of daily consumption (mean age 31.3 ± 6.97 years), and 40 age, sex, and IQ (measured using the Test de Acentuación de Palabras (Del Ser et al 1999 Brain Cogn; 33 343-56), and non-using controls (<10 lifetime uses). Structural MRI data were processed in FreeSurfer (v7.1.1), to provide measures of surface area, and cortical thickness. Whole-brain, non-parametric permutation testing was conducted with cluster-wise correction (p < .001, two-tailed; 5,000 Monte Carlo iterations), and clusters were considered significant at a corrected p of < .05.

Results

The cannabis users showed two clusters of cortical thickness reduction in the right rostral middle frontal cortex (See Fig1) (max=3.37, cluster=657.94 vertices, p=0.01; max=4.46, cluster=531.57 vertices, p=0.02). No differences were observed in cortical volume or surface area.Image 1:

Four anatomical views of a human brain showing localized activation areas in red and yellow. See long description.

Conclusions

From this study, chronic cannabis use is associated with cortical thinning in the right rostral middle frontal cortex. Further studies could examine whether these changes relate to the executive and other neuropsychological impairments reported in users.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.